Curran D - Search Results

1

Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.

Curran D, Patterson B, Varghese L, Van Oorschot D, Buck P, Carrico J, Hicks K, Lee B, Yawn B. Curran D, et al. Vaccine. 2018 Aug 9;36(33):5037-5045. doi: 10.1016/j.vaccine.2018.07.005. Epub 2018 Jul 14. Vaccine. 2018. PMID: 30017145 Free article.

2

Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination-Heplisav™ compared with Engerix-B(®) vaccine in adults.

De Ridder M, Curran D, Leroux-Roels G. De Ridder M, et al. Among authors: curran d. Vaccine. 2015 Jun 22;33(28):3161. doi: 10.1016/j.vaccine.2014.05.033. Epub 2014 Jun 2. Vaccine. 2015. PMID: 24892249 Free article. No abstract available.

3

Vaccine Timeliness: A Cost Analysis of the Potential Implications of Delayed Pertussis Vaccination in the US.

Curran D, Terlinden A, Poirrier JE, Masseria C, Krishnarajah G. Curran D, et al. Pediatr Infect Dis J. 2016 May;35(5):542-7. doi: 10.1097/INF.0000000000001071. Pediatr Infect Dis J. 2016. PMID: 26835971

4

Meta-Regression on European Zoster Incidence.

Terlinden A, Varghese L, Curran D. Terlinden A, et al. Among authors: curran d. Value Health. 2014 Nov;17(7):A666-7. doi: 10.1016/j.jval.2014.08.2459. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202432 Free article. No abstract available.

5

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?

Curran D, de Ridder M, Van Effelterre T. Curran D, et al. Hum Vaccin Immunother. 2016 Nov;12(11):2765-2771. doi: 10.1080/21645515.2016.1203495. Epub 2016 Jul 18. Hum Vaccin Immunother. 2016. PMID: 27428611 Free PMC article.

6

Contraindication of live vaccines in immunocompromised patients: an estimate of the number of affected people in the USA and the UK.

Varghese L, Curran D, Bunge E, Vroling H, van Kessel F, Guignard A, Casabona G, Olivieri A. Varghese L, et al. Among authors: curran d. Public Health. 2017 Jan;142:46-49. doi: 10.1016/j.puhe.2016.10.013. Epub 2016 Nov 18. Public Health. 2017. PMID: 28057197 Free article. No abstract available.

7

The temporal impact of aging on the burden of herpes zoster.

Varghese L, Standaert B, Olivieri A, Curran D. Varghese L, et al. Among authors: curran d. BMC Geriatr. 2017 Jan 23;17(1):30. doi: 10.1186/s12877-017-0420-9. BMC Geriatr. 2017. PMID: 28114907 Free PMC article.

8

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany.

Curran D, Van Oorschot D, Varghese L, Oostvogels L, Mrkvan T, Colindres R, von Krempelhuber A, Anastassopoulou A. Curran D, et al. Hum Vaccin Immunother. 2017 Oct 3;13(10):2213-2221. doi: 10.1080/21645515.2017.1345399. Epub 2017 Jul 14. Hum Vaccin Immunother. 2017. PMID: 28708959 Free PMC article.

9

Response to publication by Hoshi SL et al.: Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.

Curran D, Mrkvan T. Curran D, et al. Vaccine. 2017 Dec 18;35(51):7079. doi: 10.1016/j.vaccine.2017.10.045. Vaccine. 2017. PMID: 29195608 No abstract available.

10

German travelers' preferences for travel vaccines assessed by a discrete choice experiment.

Poulos C, Curran D, Anastassopoulou A, De Moerlooze L. Poulos C, et al. Among authors: curran d. Vaccine. 2018 Feb 8;36(7):969-978. doi: 10.1016/j.vaccine.2018.01.004. Epub 2018 Jan 12. Vaccine. 2018. PMID: 29338877 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

610 results

Search Page

Filters